| 32 | 1/1 | 返回列表 |
| 查看: 1551 | 回復(fù): 31 | |||
[交流]
色譜B投稿交流
|
|||
|
外審?fù)旰笈卸ù笮蓿魑粠臀铱纯矗邢M麊?br />
Comments: Dear Dr. Xueying, Thank you for submitting your manuscript to J. Chrom. B. Based on the received referee report I request a major revision of your manuscript. There are notably important parameters of your study that should be clarified according to current regulatory guidelines. Please address all comments and submit a revised version of your study for further review. Sincerely yours, Rainer Bischoff Editor in Chief Reviewer #1: The article is interesting and revision is required in improving the method development and validation as per USFDA JULY 2015 recommendation for method validation of drugs and biologic. Please find the queries as enlisted (i) Method robustness needs to be evaluated and discussed in method development (ii) Comparative and contrasting model of bio-distribution has not been cited . A reference model is required to be incorporated so that the study findings are anchored to the extant knowledge domain (iii) Need to provide statistical methods to confirm matrix effect in different lots have no impact on method. Statistical support as per USFDA JULY 2015 recommendation for method validation of drugs and biologic clearly states for such confirmatory analysis. (iv) Figures with T-joint to show there is no ion suppression or enhancement at the retention time of analyte is important and should be essentially discussed. (v) Metabolites monitoring needs to be discussed. (vi) Discussion on using ESI mode of mass spectrometry, employing liquid -liquid chromatography and reason for selecting Inertsil ®ODS3 C18 column for separation has not been clarified. (vii) Syntax errror and English usage needs to be improved throughout the paper. (viii) Authors should argue the potential of being a high-throughput method due to achieving separation from both endogenous and exogenous interfering compounds. (ix) Quality of method should be discussion with clarity against the reported literature. (x) However, considering the merit of the research highlights, the article has a potential to fit in short communication category after revision. Though the article couldn't be accepted in current form, it is suggested that authors work on the major points as discussed above and resubmit for consideration. Once again, thanking you for contributing in bio-distribution field and best wishes for your future endeavors. |
» 搶金幣啦!回帖就可以得到:
+1/462
+5/290
+1/82
+1/53
+1/52
+1/47
+1/40
+1/30
+1/18
+1/17
+1/15
+1/13
+1/11
+1/6
+1/5
+1/4
+1/3
+1/2
+1/1
+1/1
鐵桿木蟲 (職業(yè)作家)
| 32 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 279分求調(diào)劑 一志愿211 +11 | chaojifeixia 2026-03-19 | 12/600 |
|
|---|---|---|---|---|
|
[考研] 材料 336 求調(diào)劑 +3 | An@. 2026-03-18 | 4/200 |
|
|
[考研] 考研調(diào)劑求學(xué)校推薦 +3 | 伯樂29 2026-03-18 | 5/250 |
|
|
[考研] 323求調(diào)劑 +3 | 洼小桶 2026-03-18 | 3/150 |
|
|
[考研] 317求調(diào)劑 +5 | 申子申申 2026-03-19 | 9/450 |
|
|
[考研] 材料學(xué)碩297已過四六級(jí)求調(diào)劑推薦 +11 | adaie 2026-03-19 | 11/550 |
|
|
[考研] 招收調(diào)劑碩士 +4 | lidianxing 2026-03-19 | 12/600 |
|
|
[考研] 材料學(xué)碩318求調(diào)劑 +5 | February_Feb 2026-03-19 | 5/250 |
|
|
[考研] 081700化工學(xué)碩調(diào)劑 +3 | 【1】 2026-03-16 | 3/150 |
|
|
[考研] 復(fù)試調(diào)劑 +4 | z1z2z3879 2026-03-14 | 6/300 |
|
|
[考研] 化學(xué)求調(diào)劑 +3 | 臨澤境llllll 2026-03-17 | 4/200 |
|
|
[考研] 0703化學(xué) 305求調(diào)劑 +4 | FY_yy 2026-03-14 | 4/200 |
|
|
[考研] 【同濟(jì)軟件】軟件(085405)考研求調(diào)劑 +3 | 2026eternal 2026-03-18 | 3/150 |
|
|
[考研] 304求調(diào)劑 +12 | 小熊joy 2026-03-14 | 13/650 |
|
|
[考研] 085601求調(diào)劑 +4 | Du.11 2026-03-16 | 4/200 |
|
|
[考研] 275求調(diào)劑 +4 | 太陽花天天開心 2026-03-16 | 4/200 |
|
|
[論文投稿] 有沒有大佬發(fā)小論文能帶我個(gè)二作 +3 | 增銳漏人 2026-03-17 | 4/200 |
|
|
[考研] 277材料科學(xué)與工程080500求調(diào)劑 +3 | 自由煎餅果子 2026-03-16 | 3/150 |
|
|
[考研] 本科南京大學(xué)一志愿川大藥學(xué)327 +3 | 麥田耕者 2026-03-14 | 3/150 |
|
|
[考研] 復(fù)試調(diào)劑 +3 | 呼呼?~+123456 2026-03-14 | 3/150 |
|